tirzepatide in the news US-FDA has approved for chronic weight management adults with Obesity - Tirzepatide drug fast-tracked for weight

This study investigated the potential association between GLP-1RAs and SSIBs by exploring the FDA Adverse Event Reporting System (FAERS) database

Food and Drug Administration (FDA) approved Wegovy (the brand name for once-weekly Semaglutide 2.4 mg injection) for chronic weight management

And we offer real flexibility on how you fund it: - Traditional cost share - Defined contribution offerings - Manufacturer-direct cash pay Were also proud to be the only solution with published 4-year outcomes using GLPs across every workforce type: office, shift, field, and more

**A Message for Healthcare Leaders** In the GLP era: Marketing is no longer about promotion

Additional factors like the ketogenic diet, illness, surgery, and pregnancy contribute to precipitating these episodes

Tirzepatide treatment typically begins at low doses and progresses over several months, with most patients taking the medication long-term for sustained weight loss